0001641172-25-003937.txt : 20250414 0001641172-25-003937.hdr.sgml : 20250414 20250414060955 ACCESSION NUMBER: 0001641172-25-003937 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250414 DATE AS OF CHANGE: 20250414 EFFECTIVENESS DATE: 20250414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pulmotherapeutics Inc CENTRAL INDEX KEY: 0002064557 ORGANIZATION NAME: EIN: 332535852 STATE OF INCORPORATION: DE FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-543536 FILM NUMBER: 25834132 BUSINESS ADDRESS: STREET 1: 714 HUNTWICK LN CITY: TYLER STATE: TX ZIP: 75703 BUSINESS PHONE: 617-893-5088 MAIL ADDRESS: STREET 1: 714 HUNTWICK LN CITY: TYLER STATE: TX ZIP: 75703 D 1 primary_doc.xml X0708 D LIVE 0002064557 Pulmotherapeutics Inc 714 HUNTWICK LN TYLER TX TEXAS 75703 617-893-5088 DELAWARE None None Corporation true 2024 Nagarjun Konduru Venkata 714 Huntwick Ln Tyler TX TEXAS 75703 Executive Officer Director Biotechnology No Revenues 06b false 2025-03-27 false true false 10000 Indefinite 500000 Indefinite false 3 25000 true 25000 true 2.5% performance-based bonus per $1,000,000 raised 250000 The Chief Executive Officer would receive an estimated salary of $250,000 false Pulmotherapeutics Inc Nagarjun Konduru Nagarjun Konduru Venkata Chief Executive Officer 2025-04-14